<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2781">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04432051</url>
  </required_header>
  <id_info>
    <org_study_id>Gaziosmanpasa</org_study_id>
    <nct_id>NCT04432051</nct_id>
  </id_info>
  <brief_title>The Use of Lung Ultrasonography in COVID-19 Patients</brief_title>
  <official_title>The Significance of Lung Ultrasonography in the Follow-up and Treatment of COVID-19 Patients With Respiratory Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gaziosmanpasa Taksim Research and Education Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gaziosmanpasa Taksim Research and Education Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In COVID-19 patients hospitalized in the intensive care unit due to respiratory failure, lung
      ultrasonography will be tried to be given an appropriate position that will effectively use
      lung capacity and its effect on oxygenation will be investigated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, the COVID-19 patients hospitalized in the intensive care unit due to
      respiratory failure will be evaluated. Participants will be divided into two groups as
      patients undergoing lung ultrasonography (Group Ultrasonography ) and those without lung
      ultrasonography (Group Control).

      While performing lung ultrasonography, each hemithorax will be evaluated using anterior
      axillary line and posterior axillary line into anterior, lateral and posterior region, and
      each region will be divided into 6 quadrants, upper and lower. Each hemithorax will be
      scanned by the investigators, scored in 6 regions using a convex ultrasonography probe with
      the Lung Ultrasound Score (LUS score).

      Participants in both groups will be evaluated by comparing arterial blood gas analyzes before
      examination (with/without ultrasonography), at the 2nd and 12th hours. Is there any change in
      arterial blood gas values such as PO2 and PCO2 at 0, 2 and 12 hours so that oxygenation and
      ventilation between Group Ultrasonograpy and Group Control will be evaluated?
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 26, 2020</start_date>
  <completion_date type="Anticipated">August 10, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 8, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>patients will be divided into two groups, those with and without ultrasound.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in PO2 values</measure>
    <time_frame>12 hours</time_frame>
    <description>Effect of positioning on ultrasound guidance on oxygenation assessed by changes between pO2 values.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in PCO2 values</measure>
    <time_frame>12 hours</time_frame>
    <description>Effect of positioning on ultrasound guidance on ventilation assessed by changes between pCO2 values.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Ultrasonography</condition>
  <arm_group>
    <arm_group_label>GRUP Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The daily respiratory system examination of COVID-19 patients who are hospitalized in the intensive care unit is performed and the necessary mechanical ventilation applications are performed by evaluating the arterial blood gas analysis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GRUP Ultrasonography</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The daily respiratory system examination of COVID-19 patients who are hospitalized in the intensive care unit is performed and the necessary mechanical ventilation applications are performed by evaluating the arterial blood gas analysis. However, the lung of the patient will be evaluated by ultrasound and the position to use the lung capacity most appropriately will be given.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>mechanical ventilator settings and position</intervention_name>
    <description>Mechanical ventilation settings and patient position will be re-evaluated</description>
    <arm_group_label>GRUP Control</arm_group_label>
    <arm_group_label>GRUP Ultrasonography</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients have been diagnosed with COVID 19

          -  Patients in the intensive care unit over the age of 18

        Exclusion Criteria:

          -  Patients not diagnosed with COVID 19

          -  Patients with cardiac problems

          -  Patients with renal problems
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Gazoosmanpasa Education and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>SİBEL BEKTAŞ</last_name>
      <phone>090 212 945 30 00</phone>
      <email>sibel_bektas@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>June 11, 2020</study_first_submitted>
  <study_first_submitted_qc>June 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 16, 2020</study_first_posted>
  <last_update_submitted>August 6, 2020</last_update_submitted>
  <last_update_submitted_qc>August 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>lung ultrasonography</keyword>
  <keyword>intensive care unit</keyword>
  <keyword>position</keyword>
  <keyword>COVID-19</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

